The FTC said it is seeking to block Amgen’s $27.8 billion acquisition of Horizon Therapeutics, in a rare effort by antitrust enforcers to prevent a merger of pharmaceutical companies.

The FTC said it is seeking to block Amgen’s $27.8 billion acquisition of Horizon Therapeutics, in a rare effort by antitrust enforcers to prevent a merger of pharmaceutical companies. https://ift.tt/ymB7d18